Globus Medical, Inc.

Globus Medical, Inc.

GMEDยทNYSE

$77.95

-0.38%
HealthcareMedical - Devices

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. It offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative, deformity, tumors, and trauma conditions; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional pain management solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. The company also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, it distributes human cell, tissue, and cellular and tissue-based products. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

At a Glance

Live Snapshot
Market Cap$10.51B
EPS3.9800
P/E Ratio19.59
Earnings Date07/30/2026
3Y+322.0%
5Y+279.0%
10Y+338.0%
3Y+222.0%
5Y+203.0%
10Y+257.0%
3Y+518.0%
5Y+1657.0%
10Y-33376.0%
GMED

Globus Medical, Inc. Cash Conversion Engine

GMED ยท NYSE
Net Income537.87M
Depreciation & Amortization276.84M
Stock-Based Compensation49.78M
Change in Working Capital-82.71M
Others-46.95M
Capital Expenditures-164.68M
Free Cash Flow588.77M

Cash Flow Quality Analysis

FCF Conversion Rate

109.5%

Excellent cash generation. The company converts earnings to cash at or above 100%, indicating high-quality earnings.

CapEx Intensity

21.9%

Moderate capital requirements typical of many stable businesses. Healthy balance between reinvestment and cash generation.

FCF Growth Trend

+45.3%

Strong FCF growth demonstrates improving cash generation and business momentum. Positive signal for sustainability.

Working Capital Impact

-$82.71M

Minimal working capital impact on FCF. Changes in operating assets and liabilities well-managed.

Cash Flow Quality Insight

Exceptional cash generation: High-quality earnings converting to growing free cash flow. The company demonstrates strong pricing power, efficient operations, and disciplined capital allocation.

Globus Medical, Inc. Cash Flow Statement

GMED โ€ข NYSE

Globus Medical, Inc. Cash Flow StatementDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017Dec 2016Dec 2015Dec 2014Dec 2013Dec 2012Dec 2011Dec 2010Dec 2009
OPERATING ACTIVITIES
537.9M
103M
122.9M
190.2M
149.2M
102.3M
155.2M
156.5M
107.3M
104.3M
112.8M
92.5M
68.6M
73.8M
60.8M
54.5M
52M
276.8M
254M
144.7M
68.3M
69.9M
62.9M
52.7M
41.6M
42.1M
38.8M
24.1M
21.8M
19.4M
18.1M
16.9M
15.2M
13.5M
18.6M
-125.9M
-57.8M
-22.2M
-17.6M
-4.3M
4.3M
971K
8.3M
-3.8M
6.2M
-4.4M
-14.9M
-6.1M
2.1M
2M
-2.7M
49.8M
54.2M
52.7M
32.8M
30.6M
27.1M
26.1M
21.9M
14.7M
11.4M
9.6M
7.1M
5.2M
4.6M
3.3M
4M
3.5M
-47M
332.9M
97.5M
14.7M
61.5M
48.5M
7.1M
10.5M
17.7M
17.7M
12.7M
10M
8.9M
6.6M
10.6M
6.3M
5.4M
(0.0)
(158.5M)
(100.6M)
(77.8M)
(45M)
(25.4M)
(34.1M)
(30.6M)
(59.1M)
(50.1M)
(57.1M)
(51.1M)
(38.7M)
(44.9M)
(35.7M)
(28.8M)
(38.9M)
-82.7M
-97.6M
-116.6M
-105.3M
-17.3M
-37.6M
-73.4M
-49.9M
-30.5M
3.5M
-43.5M
-47.8M
6.2M
-20.6M
-17.3M
-10.7M
-39.7M
753.4M
520.6M
243.5M
178.5M
276.3M
198.8M
172M
181.6M
159.5M
171.9M
122M
79.2M
93.5M
76.5M
76.4M
71.3M
32.1M
INVESTING ACTIVITIES
-164.7M
-115.4M
-78.3M
-74M
-56.9M
-63.7M
-70.8M
-59.7M
-51.3M
-40.9M
-50.8M
-24.8M
-23.7M
-24.7M
-22.5M
-12.3M
-26M
(13.5M)
-17.6M
-296M
-31.4M
-34.5M
-33.5M
-23.8M
-14.8M
-29.9M
-76.1M
-48.5M
-36.1M
-16.8M
-6M
-7.5M
(0.0)
-3.4M
-107.5M
-113.5M
-100.6M
-419.5M
-622.4M
-223.5M
-346.5M
-537.9M
-392.9M
-287.3M
-297.7M
-251.4M
-240.9M
(0.0)
(0.0)
(0.0)
(0.0)
179.5M
70.5M
777.9M
414.7M
337.8M
203.4M
300.8M
384.4M
362.9M
334.7M
246.4M
212.3M
54.2M
0.0
0.0
300K
1.6M
-275.8M
0.0
0.0
0.0
0.0
0.0
0.0
35M
0.0
-30M
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-355M
-176.1M
(303M)
-110.4M
-375.9M
-117.3M
-140.3M
-193M
-111.3M
-99.6M
-150.6M
-100M
-227.2M
-30.7M
-30M
-12M
-27.7M
FINANCING ACTIVITIES
-300.5M
-85.8M
-225.6M
-144.5M
0.0
-104.7M
31M
39.3M
11.7M
5.9M
5.5M
9.7M
7.6M
22.5M
-9.1M
1.3M
918K
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
0.0
-5.3M
-340K
327K
-300.5M
-85.8M
-225.6M
-144.5M
(0.0)
-104.7M
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
(0.0)
-10M
(0.0)
(0.0)
-378.7M
58.1M
-6.3M
34.5M
54.1M
66M
-6.6M
-6.7M
-10.1M
-5.4M
850K
3.2M
3.5M
1.6M
-346K
787K
249K
-679.2M
-27.7M
-231.8M
-110M
54.1M
-38.7M
24.4M
32.6M
1.6M
2M
6.3M
12.9M
11M
24M
-14.7M
1.8M
1.5M
CASH FLOW SUMMARY
22.4M
255K
2.2M
-747K
-810K
865K
-156K
-256K
2M
-1.9M
153K
185K
230K
-97K
-722K
-2K
50K
-258.3M
317.1M
316.8M
-42.6M
-46.3M
43.7M
56M
20.9M
51.9M
72.5M
-22.1M
-7.7M
-122.4M
69.7M
31M
61.1M
5.9M
784.4M
467.3M
150.5M
193.1M
239.4M
195.7M
139.7M
118.8M
67M
60.2M
82.3M
90M
212.4M
142.7M
111.7M
50.7M
44.7M
526.2M
784.4M
467.3M
150.5M
193.1M
239.4M
195.7M
139.7M
118.8M
132.6M
60.2M
82.3M
90M
212.4M
142.7M
111.7M
50.7M
588.8M
405.2M
165.2M
104.4M
219.4M
135.1M
101.2M
121.9M
108.2M
131M
71.2M
54.4M
69.8M
51.8M
53.9M
59M
6.1M

SEC Filings

GMED - Filing history and reports

Filing TypeFiling DatePeriod EndingFiscal YearActions
10-Q

10-Q 2026 Q1

Q1

May 07, 2026
March 31, 2026
2026
8-K

8-K 2026

N/A

May 07, 2026
May 07, 2026
2026
DEF 14A

DEF 14A 2026

N/A

April 24, 2026
June 03, 2026
2026
8-K

8-K 2026

N/A

March 23, 2026
March 23, 2026
2026
8-K

8-K 2026

N/A

February 24, 2026
February 24, 2026
2026
10-K

10-K 2025 FY

FY

February 24, 2026
December 31, 2025
2025
8-K

8-K 2026

N/A

January 07, 2026
January 07, 2026
2026
10-Q

10-Q 2025 Q3

Q3

November 06, 2025
September 30, 2025
2025
8-K

8-K 2025

N/A

November 06, 2025
November 06, 2025
2025
10-Q

10-Q 2025 Q2

Q2

August 07, 2025
June 30, 2025
2025
Showing 1 to 10 of 210 filings